BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Endocrine gland cancer AND CDKN1B, CDKN4, 1027, ENSG00000111276, MEN4, P27KIP1, P46527, MEN1B, KIP1
475 results:

  • 1. To diagnose primary and secondary squamous cell carcinoma of the thyroid with ultrasound malignancy risk stratification.
    Zhang X; Wei B; Nong L; Zhang H; Zhang J; Ye J
    Front Endocrinol (Lausanne); 2023; 14():1238775. PubMed ID: 38495474
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. HIF-2α-dependent TGFBI promotes ovarian cancer chemoresistance by activating PI3K/Akt pathway to inhibit apoptosis and facilitate DNA repair process.
    Ma S; Wang J; Cui Z; Yang X; Cui X; Li X; Zhao L
    Sci Rep; 2024 Feb; 14(1):3870. PubMed ID: 38365849
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Updates on the genetics of multiple endocrine neoplasia.
    Sahakian N; Castinetti F; Romanet P; Reznik Y; Brue T
    Ann Endocrinol (Paris); 2024 Apr; 85(2):127-135. PubMed ID: 38325596
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. DIRAS3 induces autophagy and enhances sensitivity to anti-autophagic therapy in KRAS-driven pancreatic and ovarian carcinomas.
    Bildik G; Gray JP; Mao W; Yang H; Ozyurt R; Orellana VR; De Wever O; Carey MS; Bast RC; Lu Z
    Autophagy; 2024 Mar; 20(3):675-691. PubMed ID: 38169324
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Molecular characterization of large cell calcifying sertoli cell tumors: A multi-institutional study of 6 benign and 2 malignant tumors.
    Abdulfatah E; Al-Obaidy KI; Robinson D; Wu YM; Heider A; Idrees MT; Ulbright TM; Kunju LP; Wu A
    Hum Pathol; 2024 Feb; 144():15-21. PubMed ID: 38154678
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Cross-Disciplinary Approach of Adrenal Tumors: Insights into Primary Aldosteronism-Related Mineral Metabolism Status and Osteoporotic Fracture Risk.
    Trandafir AI; Gheorghe AM; Sima OC; Ciuche A; Petrova E; Nistor C; Carsote M
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139166
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Risk factors for postoperative pancreatic fistula following non-traumatic, pancreatic surgery. Retrospective observational study.
    Mostafa A; Habeeb TA; Neri V; Elshahidy TM; A Fiad A
    Ann Ital Chir; 2023; 94():435-442. PubMed ID: 38051507
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Genetic testing in prolactinomas: a cohort study.
    Boukerrouni A; Cuny T; Anjou T; Raingeard I; Ferrière A; Grunenwald S; Maïza JC; Marquant E; Sahakian N; Fodil-Cherif S; Salle L; Niccoli P; Randrianaivo H; Sonnet E; Chevalier N; Thuillier P; Vezzosi D; Reynaud R; Dufour H; Brue T; Tabarin A; Delemer B; Kerlan V; Castinetti F; Barlier A; Romanet P
    Eur J Endocrinol; 2023 Dec; 189(6):567-574. PubMed ID: 37956455
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical Factors Predicting Multiple endocrine Neoplasia Type 1 and Type 4 in Patients with Neuroendocrine Tumors.
    Faggiano A; Fazzalari B; Mikovic N; Russo F; Zamponi V; Mazzilli R; Guarnieri V; Piane M; Visco V; Petrucci S
    Genes (Basel); 2023 Sep; 14(9):. PubMed ID: 37761922
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. DNA Methylation Pattern in Somatotroph Pituitary Neuroendocrine Tumors.
    Kober P; Rymuza J; Baluszek S; Maksymowicz M; Nyc A; Mossakowska BJ; Zieliński G; Kunicki J; Bujko M
    Neuroendocrinology; 2024; 114(1):51-63. PubMed ID: 37699356
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Multiple endocrine neoplasia type 4 (men4): a thorough update on the latest and least known men syndrome.
    Ruggeri RM; Benevento E; De Cicco F; Grossrubatscher EM; Hasballa I; Tarsitano MG; Centello R; Isidori AM; Colao A; Pellegata NS; Faggiano A
    Endocrine; 2023 Dec; 82(3):480-490. PubMed ID: 37632635
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Regional Collaboration and Trends in Clinical Management of Thyroid cancer.
    van Dijk SPJ; Coerts HI; Lončar I; van Kinschot CMJ; von Meyenfeldt EM; Edward Visser W; van Noord C; Zengerink HF; Ten Broek MRJ; Verhoef C; Peeters RP; van Ginhoven TM
    Otolaryngol Head Neck Surg; 2024 Jan; 170(1):159-168. PubMed ID: 37595096
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Genetic and clinical screening for hereditary primary hyperparathyroidism in a large Chinese cohort: a single-center study.
    Song A; Yang Y; Jiang Y; Nie M; Jiang Y; Li M; Xia W; Xing X; Wang O
    J Bone Miner Res; 2023 Sep; 38(9):1322-1333. PubMed ID: 37449924
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Pituitary Tumorigenesis-Implications for Management.
    Vamvoukaki R; Chrysoulaki M; Betsi G; Xekouki P
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109772
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Osteocalcin modulates parathyroid cell function in human parathyroid tumors.
    Verdelli C; Tavanti GS; Forno I; Vaira V; Maggiore R; Vicentini L; Dalino Ciaramella P; Perticone F; Lombardi G; Corbetta S
    Front Endocrinol (Lausanne); 2023; 14():1129930. PubMed ID: 37065733
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Pituitary tumours: molecular and genetic aspects.
    De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
    J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Novel germline variants of cdkn1b and CDKN2C identified during screening for familial primary hyperparathyroidism.
    Mazarico-Altisent I; Capel I; Baena N; Bella-Cueto MR; Barcons S; Guirao X; Albert L; Cano A; Pareja R; Caixàs A; Rigla M
    J Endocrinol Invest; 2023 Apr; 46(4):829-840. PubMed ID: 36334246
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [MEN for multiple endocrin neoplasms: When evokate MEN? Update 2022].
    Duval M; Haissaguerre M
    Rev Med Interne; 2023 Jan; 44(1):12-18. PubMed ID: 36307322
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Germline cdkn1b variant type and site are associated with phenotype in men4.
    Halperin R; Arnon L; Nasirov S; Friedensohn L; Gershinsky M; Telerman A; Friedman E; Bernstein-Molho R; Tirosh A
    Endocr Relat Cancer; 2023 Jan; 30(1):. PubMed ID: 36256846
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
    Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
    Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 24.